What is she best known for?
The fields of study she is best known for:
- Cancer
- Gene
- Internal medicine
Her scientific interests lie mostly in Leukemia, Myeloid leukemia, Internal medicine, Oncology and Immunology.
Her biological study spans a wide range of topics, including Cancer, Myeloid, Cancer research, Fms-Like Tyrosine Kinase 3 and NPM1.
Her Myeloid leukemia research is multidisciplinary, incorporating perspectives in Genetics, Molecular biology, BAALC, Cytogenetics and Core binding factor acute myeloid leukemia.
Her Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology and Surgery.
Her research investigates the connection between Oncology and topics such as Clinical trial that intersect with issues in Decitabine.
In her study, European LeukemiaNet is inextricably linked to Intensive care medicine, which falls within the broad field of Acute leukemia.
Her most cited work include:
- Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. (11046 citations)
- The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia (3662 citations)
- The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes (3594 citations)
What are the main themes of her work throughout her whole career to date?
Her primary areas of investigation include Leukemia, Internal medicine, Myeloid leukemia, Oncology and Immunology.
Her Leukemia research is multidisciplinary, relying on both Cancer, Myeloid, Pathology, BAALC and NPM1.
Her study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology and Surgery.
Her research in Myeloid leukemia focuses on subjects like Cytogenetics, which are connected to Karyotype.
The various areas that she examines in her Oncology study include Acute promyelocytic leukemia, European LeukemiaNet, Survival analysis and Transplantation.
Her Cancer research research includes elements of Haematopoiesis, Gene expression profiling, Mutation, Gene mutation and microRNA.
She most often published in these fields:
- Leukemia (47.10%)
- Internal medicine (46.29%)
- Myeloid leukemia (42.90%)
What were the highlights of her more recent work (between 2016-2021)?
- Myeloid leukemia (42.90%)
- Internal medicine (46.29%)
- Leukemia (47.10%)
In recent papers she was focusing on the following fields of study:
Clara D. Bloomfield mainly investigates Myeloid leukemia, Internal medicine, Leukemia, Oncology and Cancer research.
Clara D. Bloomfield interconnects Myeloid, Gene mutation, Stem cell, NPM1 and Long non-coding RNA in the investigation of issues within Myeloid leukemia.
Her Myeloid study incorporates themes from Survival rate, Adult Acute Myeloid Leukemia, Chromosome and Decitabine.
Immunology covers Clara D. Bloomfield research in Leukemia.
In her research on the topic of Oncology, Family medicine is strongly related with Clinical trial.
Her study looks at the relationship between Cancer research and topics such as Chromosomal translocation, which overlap with Brachial Plexus Neuritis.
Between 2016 and 2021, her most popular works were:
- Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel (2002 citations)
- Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation (802 citations)
- High Frequency and Poor Outcome of Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia in Adults. (172 citations)
In her most recent research, the most cited papers focused on:
- Cancer
- Gene
- Internal medicine
Clara D. Bloomfield focuses on Internal medicine, Myeloid leukemia, Leukemia, Myeloid and Oncology.
Myeloid leukemia is a subfield of Cancer research that Clara D. Bloomfield tackles.
Leukemia is a subfield of Immunology that Clara D. Bloomfield studies.
Her work on Antibody as part of general Immunology study is frequently linked to EGFL7, therefore connecting diverse disciplines of science.
Her studies in Myeloid integrate themes in fields like Cancer, Hematopoietic stem cell transplantation, Survival rate, Decitabine and Nonsense mutation.
Her Oncology research incorporates elements of Missense mutation, Targeted Mutation, Tyrosine kinase, Adult Acute Myeloid Leukemia and Frameshift mutation.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
